Which physicians are affected most by medicaid preferred drug lists for statins and antihypertensives?

Medicine & Life Sciences

• Medicaid 63%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 55%
• Antihypertensive Agents 52%
• Physicians 36%
• Pharmaceutical Preparations 23%
• Prescriptions 14%
• Physicians' Practice Patterns 10%
• Prescription Drugs 7%
• Costs and Cost Analysis 6%
• Prior Authorization 5%
• Private Practice 3%
• Cardiologists 3%
• Primary Care Physicians 3%
• Vulnerable Populations 3%
• Medicare 3%
• Health Expenditures 3%
• Outpatients 2%
• Health Care Outcome Assessment 2%

Social Sciences

• drug list 100%
• physician 43%
• medication 28%
• drug 11%
• costs 6%
• available information 4%
• authorization 4%
• expenditures 3%
• minority 2%
• time 1%